Studying genes and molecules behind childhood liver cancers
Studies the genes and molecules of liver cancers in children.
Plain-language title generated from the registry record
Registry title: Molecular Basis of Pediatric Liver Cancer
Key facts
- Where
- Pittsburgh, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 0 and 99 years old?
Source: NCT03959800, who can take part
Where in United States
- UPMC Children's Hospital of PittsburghPittsburgh, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Pittsburgh
- Trial code
- NCT03959800
- Record updated
- 10 August 2026
- Original description
The purpose of this retrospective and prospective project is to understand the molecular and genetic basis of liver cancer of childhood. Understanding the molecular and genetic bases of liver cancers can offer a better classification based on tumor biology, mechanisms and predisposition.Read full original descriptionShow less
Genetic and Molecular Basis of Pediatric Liver Cancer
The purpose of this retrospective and prospective project is to understand the molecular and genetic basis of liver cancer of childhood. Understanding the molecular and genetic bases of liver cancers can offer a better classification based on tumor biology, mechanisms and predisposition.
Inclusion: Prior or current treatment for a childhood liver tumor, malignant or benign, at age <21 years; Biological parents and siblings of eligible children.
Exclusion: No prior or current treatment for a childhood liver tumor; Non-biological parents, legal guardians, or non-biological siblings of eligible children.